SCHEMBL2498875

SCHEMBL2498875

CC(C(=O)O)[C@H](c1cccc(O)c1)C1CCC1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 18/20 0.55
LMNA P02545 1/20 0.46
HIF1A Q16665 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17494791 1.00 FFAR1 (0.55) FFAR1LMNAHIF1AKDM4E
SCHEMBL19181046 1.00 FFAR1 (0.55) FFAR1LMNAHIF1AKDM4E
SCHEMBL2497755 1.00 FFAR1 (0.55) FFAR1LMNAHIF1AKDM4E
SCHEMBL2495219 0.94 FFAR1 (0.60) FFAR1LMNAHIF1A
SCHEMBL2504420 0.94 FFAR1 (0.60) FFAR1LMNAHIF1A
SCHEMBL15973410 0.94 FFAR1 (0.60) FFAR1LMNAHIF1A
SCHEMBL22717197 0.94 FFAR1 (0.60) FFAR1LMNAHIF1A
SCHEMBL19201873 0.85 FFAR1 (0.45) FFAR1
SCHEMBL17537791 0.85 FFAR1 (0.45) FFAR1
SCHEMBL15971969 0.79 FFAR1 (0.49) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030354-B2 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes AMGEN INC. (US) 2011-10-04 US disclosed